These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18175284)

  • 41. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
    Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
    Lotta LA; Lombardi R; Mariani M; Lancellotti S; De Cristofaro R; Hollestelle MJ; Canciani MT; Mannucci PM; Peyvandi F
    J Thromb Haemost; 2011 Sep; 9(9):1744-51. PubMed ID: 21726405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ADAMTS-13 regulates platelet adhesion under flow. A new method for differentiation between inherited and acquired thrombotic thrombocytopenic purpura.
    Shenkman B; Budde U; Angerhaus D; Lubetsky A; Savion N; Seligsohn U; Varon D
    Thromb Haemost; 2006 Aug; 96(2):160-6. PubMed ID: 16894459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13.
    Kostousov V; Fehr J; Bombeli T
    Thromb Res; 2006; 118(6):723-31. PubMed ID: 16430944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
    Dong JF; Moake JL; Nolasco L; Bernardo A; Arceneaux W; Shrimpton CN; Schade AJ; McIntire LV; Fujikawa K; López JA
    Blood; 2002 Dec; 100(12):4033-9. PubMed ID: 12393397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura.
    Sadler JE
    Hematology Am Soc Hematol Educ Program; 2015; 2015(1):631-6. PubMed ID: 26637781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombotic thrombocytopenic purpura and anti-thrombotic therapy targeted to von Willebrand factor.
    Zhou Z; Dong JF
    Curr Vasc Pharmacol; 2012 Nov; 10(6):762-6. PubMed ID: 22022775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Von Willebrand factor--cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report.
    Nakazawa Y; Hashikura Y; Urata K; Ikegami T; Terada M; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y; Miyagawa S
    Liver Transpl; 2003 Dec; 9(12):1328-33. PubMed ID: 14625834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
    Moake JL
    Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation.
    Kentouche K; Zintl F; Angerhaus D; Fuchs D; Hermann J; Schneppenheim R; Budde U
    Semin Thromb Hemost; 2006 Mar; 32(2):98-104. PubMed ID: 16575684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.
    Peyvandi F; Ferrari S; Lavoretano S; Canciani MT; Mannucci PM
    Br J Haematol; 2004 Nov; 127(4):433-9. PubMed ID: 15521921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
    Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The emerging concept of residual ADAMTS13 activity in ADAMTS13-deficient thrombotic thrombocytopenic purpura.
    Lotta LA; Wu HM; Musallam KM; Peyvandi F
    Blood Rev; 2013 Mar; 27(2):71-6. PubMed ID: 23415418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ADAMTS-13 assays in thrombotic thrombocytopenic purpura.
    Peyvandi F; Palla R; Lotta LA; Mackie I; Scully MA; Machin SJ
    J Thromb Haemost; 2010 Apr; 8(4):631-40. PubMed ID: 20088924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study.
    Lancellotti S; Peyvandi F; Pagliari MT; Cairo A; Abdel-Azeim S; Chermak E; Lazzareschi I; Mastrangelo S; Cavallo L; Oliva R; De Cristofaro R
    Thromb Haemost; 2016 Jan; 115(1):51-62. PubMed ID: 26272487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.
    Veyradier A; Obert B; Houllier A; Meyer D; Girma JP
    Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura.
    Zheng XL
    J Thromb Haemost; 2024 May; 22(5):1358-1365. PubMed ID: 38360215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.